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Abstract  
Over the last two decades, the C-section rate has increased worldwide. It is understood that 
colonization patterns of intestinal microbiota in infant delivery in C-section vary from those that 
were delivered vaginally. These different microbial pattern and diversity will impact and respond to 
immune and dysbiosis-related diseases. This article examined the effect of C-section on gut 
microbiota in children.  
Recent findings: Newborns are influenced by various factors, including mode of delivery, feeding, 
nutrition, hospitalization, antibiotic and host gene. Several studies have shown that infants with C-
section have lower Bifidobacterium while others have shown lower abundance of 
Enterobactericeae and Bacteroides in infants with C-section compared to infants born vaginally. 
Although the mode of delivery is only one factor that influences infant microbiota composition, 
studies conclude that reduced microbial exposure during the C-section is important because it can 
affect dysbiosis several years after birth. Good microbiota is a key source of microbial-driven 
immune regulation, changes in normal patterns of bacterial colonization can alter the immune 
development outcome and may predispose to certain immune-related disorders later in life. 
Summary: The composition and concentrations of intestinal microbiota between vaginally and C-
section born infants are significantly different. Among C-section infants, gut microbiota is 
associated with lower diversity and therefore induces dysbiosis, which can affect immune 
development and may predispose to some immune disorders, i.e. allergies in particular. Nutritional 
approach with pre-, probiotics, and/or synbiotics can have a promising effect early in life in 
preventing gut dysbiosis.  
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Introduction 
 
The term ‘microbiota’ refers to the number of all 
microbial colonies living in or on the human body. 
The human gut, primarily the large intestine,  
 
contains 1014 bacteria, the body’s largest numbers of 
microbiota compared to certain human bodies such 
as skin, vagina, mouth and ears. Gut microbiota 
coexists with host in a homeostatic relationship and 
has bidirectional interaction with the immune 
system. In the first year of life, the production of gut 
microbiota is a complex process and an important 
process in the human life cycle as it plays a key role 
in immunological and metabolic processes, thereby 
affecting human health and diseases.1  
The pioneering bacteria colonizing infant 
intestine and its shift towards a stable ecosystem are 
crucial to the development of optimal interaction 
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(symbiosis).2 Tissier published the idea in 1900 that 
fetuses are sterile in utero and microbial 
colonization begins later during and after birth, this 
is recognized for centuries. In comparison, studies 
have shown that uterine microbiota is associated 
with healthy term pregnancies and there is potential 
for placental barrier bacterial transmission. Recent 
studies have detected bacteria from healthy 
newborns in placenta tissue, umbilical cord blood, 
amniotic fluid, meconium and fetal membranes with 
no sign of infection or inflammation.2,3  
The human bowel is easily colonized by a large 
variety of microbes and is distinctive in 
composition, but over 95% can be allocated to four 
main phylas: Firmicutes, Bacteroidetes, 
Actinobacteria and Proteobacteria.3 The formation 
of microbiota starts at birth and plays an important 
role in host immune system maturation, defending 
against pathogens and providing nutrients.4  
Influenced by many factors, the diversity and 
colonization patterns of infant gut microbiota 
include pregnancy, mode of delivery (vaginal vs 
Caesarean section), diet (breast milk vs formula), 
sanitation, and antibiotic treatment.5  
The newborns’ first big exposure to microbes 
happens during birth and significantly influenced by 
delivery methods.3 The skin, gut, oral and 
nasopharyngeal cavities of the vaginally-born 
neonates are initially seeded by Lactobacillus spp, 
which resembles maternal vaginal microbiota. The 
absence of Lactobacillus spp and dominance of 
specific skin and environmental microbes such as 
Staphylococcus, Streptococcus or Propionibacteria 
is found in infants delivered by Caesarean section 
(C-section).6,7 These initial microbiota evolve over 
time and are adapting to the body and formed by the 
availability of different nutrients. Recent study 
showed that although the difference between 
delivery modes gradually decreased at 4 months and 
12 months of age, C-section-born infants remained 
have more heterogeneous gut microbiota  compared 
to the vaginally-born.3  
The rate of C-section has been increasing 
worldwide over the last two decades. It is observed 
that intestinal colonization patterns of infant 
delivery in C-section vary from those that were 
vaginally delivered. However, the relationship 
between these trends and delivery mode is still 
unclear. Various colonization patterns and diversity 
of the intestinal microbiota can impact and respond 
to immune development and also with several 
illnesses associated with changes of the intestinal 
microbiota (dysbiosis).8 Thus, this article analyzes 
the relationship of Caesarean section (C-section) 
delivery and its effect on the gut microbiota of 
children. 
 
Methods 
 
This article reviewed how C-Section affect gut 
microbiota and its effect on children. We focus on 
gut microbiota, the difference between different 
delivery method on gut microbiota, and how it affect 
children’s health. Articles included in this review are 
from several electronic database i.e Pubmed, 
Medline and Google Scholar with the key words 
“mode of delivey”, “ceasarean section”, “gut 
microbiota”, “dybiosis”, “prebiotics”, “probiotics” 
and “synbiotics”. Articles included are the one in 
English or Indonesia language and published from 
April 2010 until April 2020. 
 
Results and Discussion 
 
Gut microbiota within the first 100 days of life 
 
The sterility of uterus and microbial colonization of 
newborn is generally recognized since 1900. This 
view is based on the fact that microbial analyses in 
pregnancy-related samples were conducted only in 
cases of suspected infection. It is also discussed as 
culture studies have shown that microbes are found 
in placenta, amniotic fluid, fetal membrane, 
umbilical cord blood and meconium.2 
Nearly half of the umbilical cord samples and all 
of the meconium samples contain bacteria from 
cultivable sources such as Enterococcus, 
Streptococcus, Staphylococcus and 
Propionibacterium, as well as human placental 
bacteria Bifidobacterium and Lactobacillus.4 The 
mechanism by which gut bacteria enter human 
uterus is not fully understood. Several studies have 
shown that certain bacteria from the maternal 
digestive tract can spread in healthy host to extra 
digestive locations. The mechanism consists of 
dendritic cells and CD18+ cells that may take non-
pathogenic bacteria from the intestinal lumen and 
transport them to other locations.9 However, 
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dendritic cells may open tight intersections between 
intestinal epithelial cells, send dendrites out of the 
epithelium and directly sample bacteria without 
damaging the epithelial barrier. It has also been 
shown that small numbers of dendritic intestinal 
cells can maintain live commensal bacteria in 
mesenteric lymph nodes for several days. Dendritic 
cells and/or macrophages, once within the lymph 
nodes, can spread elsewhere because lymphocytes 
circulate in the associated lymphoid system.9,10 This 
hypothesis is confirmed by a study which found 
Enterococcus faecium in amniotic fluid and 
meconium following sterile C-section of pregnant 
mice previously inoculated with the bacteria.2 This 
could be transferred to the fetus via the bloodstream. 
A recent research has also found that microbiota is 
present in human placenta and has shown that it can 
be the route for maternal oral bacteria to be given to 
fetus like microbiota in the oral cavity.11 The 
microbial interaction in prenatal life is thus seen, but 
previous studies have not used techniques to 
quantify the number of bacterial cells and to 
differentiate accurately between DNA, dead cells, 
living cells and active cells that make it difficult to 
identify placental microbiota or pregnancy risk 
factors.11 It requires further research to validate the 
presence, amount and effect of intrauterine 
microbiota on the health of children. 
Post-natal microbial interaction is higher and 
extensive during birth and breastfeeding than in 
prenatal life. Newborns’ first exposure to microbes 
happens during the birth process and may differ 
according to delivery method. Lactobacillus spp is 
dominant in vaginally-delivered newborns but 
different species are present in each newborn 
because of various motherly vaginal microbiota. 
Newborns therefore continue to live exposed to 
various bacterial species, depending on interaction 
with vaginal flora. In comparison, C-section born 
children showed various Staphylococcus, 
Streptococcus, Clostridium or Propionibacterium 
colonization. This indicates that early colonization 
benefits bacterial communities associated with each 
mode of delivery.6,12 
In newborns, gut microbiota has a low diversity 
and characterized by the relative prevalence of the 
phyla Proteobacteria and Actinobacteria. The 
colonization begins first with optional anaerobic 
species, followed by the creation of compulsory 
anaerobes organisms such as Bifidobacterium, 
Bacteroides and Clostridium. Full-term breast-fed 
infants show dominance of compulsory anaerobic 
bacteria, such as Bifidobacteria in the gut, while 
premature infants show lower bacteria but lower 
facultative anaerobes such as Enterobacteriaceae 
and Enterococcaceae. In addition, the proliferation 
and dominance of other bacteria, such as Firmicutes 
and Bacteroidetes diversify the microbiota. Finally, 
by the end of the first year of life, children microbial 
profile start to resemble that in adult, and by 2-3 
years of life have developed their signature 
microbial profile.3,13  
Newborn microbiota is a complex ecosystem 
that is influenced by various factors such as delivery 
mode, feeding/dieting, medication, hospitalization 
and host gene. Demographic factors such as gender, 
gestational age and postnatal age also contribute in 
the development of gut microbiota. These 
contributing factors have been identified in several 
studies, and most have shown that interaction 
between host-microbial products and their different 
factors play an important role in infant health and 
immune development processes.13,14   
 
Impact of C-section and gut dysbiosis in children 
 
There are many factors influencing the production of 
gut microbiota such as delivery mode, diet, genetics, 
health status, gestational age, etc. Breast milk 
encourages intestinal microbiota production by 
adding probiotics and prebiotics and providing 
protection to pathogens. Lactobacillus, 
Bifidobacterium, Staphylococcus, Bacteroides, 
Enterococcus, Streptococcus and Clostridium are 
several examples of breast milk bacteria. These 
bacteria are evident in breast milk and neonatal 
feces, which indicate vertical transmission of 
bacteria through breastfeeding. Full-term infants 
that are exclusively breastfed tend to have more 
Bifidobacterium, but less diverse gut microbiota 
compared to formula-fed infants. When children are 
exposed to solid food, the gut microbiota pattern 
shifts towards adult microbiota pattern at around 12 
months of age.13  
The use of antibiotics will alter the microbial 
diversity and affect the health of children. Short-
term use of antibiotics will significantly affect the 
colonization and diversity of gut microbiota. Good 
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microbiota diversity has been shown to decrease 
significantly in the first three weeks of life in infants 
with longer-term antibiotics treatment, compared 
with infants exposed to short-term antibiotics. In 
infants, it is shown that after antibiotic treatment, the 
colonization pattern of Bifidobacterium decreases 
while Proteobacteria increases. Preterm infants are 
often delivered through C-section and the use of 
antibiotics in this situation is common. In this case, 
the evolving pattern of microbiota may be associated 
with a serious intestinal disorder, such as neonatal 
necrotizing enterocolitis (NEC).15 
Initial microbial exposure occurs during and 
shortly after birth, as described. The newborn’s first 
high exposure to microbes occurs during childbirth 
and relies heavily on mode of delivery.13 In infants 
born vaginally and via the C-section, different 
bacterial colonization occurs. Vaginal bacteria are 
transmitted from mother to child during vaginal 
birth, primarily Lactobacilli, while infants born with 
C-section have microbial pattern resembling 
environmental microbes.6,8,12 It is known that in 
infants born with C-section, the gut microbiota in the 
first week of life is less diversed compared with 
those delivered vaginally. Nevertheless, the pattern 
of colonization of its phylum is not affected by the 
mode of delivery. Some studies have shown lower 
Bifidobacterium and Enterobactericeae in C-section 
infants compared with those delivered vaginally. 
Meanwhile, Clostridium genus is more common in 
C-section delivered infants. Four studies have 
indicated that the Bacteroides phylum was less 
diversed among infants delivered in C-section 
within the first week, and two studies have shown 
that there is no significant difference within the 
Firmicute phylum between C-section and vaginally-
delivered infants.8 
C-section has saved many lives but has become 
overperformed, often with no or weak indications, 
over the last decades. In creating “good” gut 
microbiota profile, the existence of 
healthy/abundant diversity plays a decisive role. 
Increased C-section rate, prematurity, antibiotics 
usage, improvements in feeding and the 
environment, may have affected gut microbiota. The 
transformation of microbial communities at risk of 
dysbiosis (microbial imbalance). Microbiota plays a 
key role via symbiosis in humans (controllable 
benefits), which may lead to short-term 
inflammation that leads to children’s gastrointestinal 
disorders. Several studies have shown that dysbiosis 
of children coincides with emerging immune 
changes (asthma), inflammatory bowel disease and 
metabolic (obesity) disorders.16 
A balanced relationship between the host 
microbiota and the immune system is essential for a 
homeostatic toward pathogenic attack and avoid 
inflammation. Infants with dysbiosis gut foster a 
strong T-helper (Th)-1 bias, which makes the 
immune system susceptible to inflammation hence 
secreting cytokines Interleukin (IL)-12 and 
Interferon (IFN)-𝛾. This inflammation affects tissue 
and tissue repair, disturbing the normal immune 
system, potentially leading to long-term 
consequences such as inflammatory bowel disease 
(IBD), allergy and autoimmune disease.3 
C-section born infants have a lower diversity of 
microbiota compared with vaginally born infants, 
especially on Bacteroides colonization. B. fragilis 
which significantly higher in infants born vaginally, 
has been shown to have an anti-inflammatory role 
by acting on T cells. B. fragilis produces surface 
polysaccharide A (PSA), a microorganism-
associated molecular pattern (MAMP) that is 
recognized by toll-like receptor 2 (TLR 2) on T cells. 
Engagement of TLR2 and PSA leads to T cell 
induction and limits Th-17 response which will 
promote tolerance and immunosuppression in the 
gut.3 Appropriate microbial stimulation during 
infancy is required to develop Th1-like and T-cell 
response. Difference in infants gut microbiota could 
shape later immune responsiveness, influencing Th1 
maturation may impact on immune mediated 
disease.17 Lower microbial diversity might explain 
why infants born by C-section are associated with 
the development of allergy and asthma, type-1 
diabetes, and obesity.3,14,17 
 
Gut dysbiosis and its impact on health 
 
Inadequate transfer of maternal microbiome to 
infants born through C-section may lead to impaired 
immunological development. Although mode of 
delivery is only one factor that influences the 
composition of infant microbiota, studies conclude 
that reduced microbial exposure during C-section is 
important because it may cause dysbiosis several 
years after birth. Gut microbiota is an important key 
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source of microbial-driven immune regulation. 
Alterations of the normal bacterial colonization 
patterns may change the outcome of immune 
development and may predispose to certain 
immune-related disorders later in life, such as 
allergy, obesity or diabetes.18 
The development of the newborn immune 
system depends on the gut microbiota composition 
in early life. Hypothesis on microbial deprivation 
syndrome in economically-developed countries and 
its association with high incidence of multiple 
sclerosis, type-1 diabetes and Crohn’s disease has 
been proposed.19 Low-diversity microbiota leads to 
insufficient T-cell induction with regulatory and/or 
Th1-like properties to counteract Th2 response in 
induced allergies. Early exposure to diverse gut 
microbiota is important as the distribution of 
specific microbial species in immune maturation. 
Repeated exposure to new microbial antigens may 
enhance the development of immune response 
through Th1-like responses.17 A study using culture-
independent bacterial molecular techniques 
concludes low gut microbiota diversity during 
childhood in children with eczema or sensitization.14 
Indeed, a number of cross-sectional epidemiological 
studies showed differences in the composition and 
activity of gut microbiota among healthy and atopic 
children. Asthma incidence was also linked to 
abnormal microbiota in pediatric populations.19 A 
study reported that gut microbiota depletion at 3 
months of age was found in subjects with atopy and 
wheeze. In this group, biosynthesis of lipo-
polysaccharides and short-chain fatty acid (SCFA) 
acetate is also reduced.3 
Gut microbiota also contributes to the 
production of SCFA in fat tissues to the formation 
of triglycerides block through fermentation of 
indigestible polysaccharide-derived plants. 
Kalliomaki20 found lower intestinal Bifidobacterium 
and higher concentration of Staphylococcus aureus 
at 6 and 12 months in obese children compared to 
children with normal weight. Alterations in early 
exposures to microbiota (such as C-section 
delivery), lack of breastfeeding, maternal pregnancy 
BMI, and infants antibiotics, may alter the diversity 
of microbiota and may influence the risk of 
overweight in later childhood.  
Aberrant gut microbiota colonization can affect 
the immune system in adulthood, making it more 
susceptible to certain diseases.  Persistent increases 
in natural killer cells can only be prevented by 
neonatal colonization of the microbiota, and 
microbiota also drives the generation of T cell that 
control inflammation. IgA secretion and 
inflammatory cytokine profiles are also influenced 
by gut microbiota. This conclude that immune 
disturbance may be caused by altered gut 
microbiota, which explains the increased risk of 
autoimmune disorders in adulthood.18 
 
C-section, gut dysbiosis and allergies 
 
The most common chronic disease in childhood is 
allergic diseases. Allergic disease is an immune-
mediated disease that has increased considerably 
over the past decades with a high increase in C-
section deliveries. 2 There are reports that there is a 
risk of developing allergic disease, allergic rhinitis, 
asthma and asthma-related hospitalization, and food 
allergy, whereas there was no association with 
inhalant atopy and eczema/atopic dermatitis.21,22 As 
already mentioned, gut microbiota plays an 
important role in improving immune system 
development and maturation. Gut dysbiosis has been 
shown to be associated with atopic children in 
several studies. Allergic infants have been found to 
have less Bifidobacterium colonization than in non-
allergic infants. 23 Reduced exposure to microbial 
antigens to the gut explain immune system 
dysregulation. To develop a more balanced immune 
phenotype, appropriate microbial stimulation during 
childhood, including maturation of Th1-like 
responses and appropriate development of 
regulatory T-cell response is required. The 
imbalance in gut microbiota has affected the Th1 
ripening pathway showing that children born 
through C-section have lower levels of Th-1 
chemokines CXCL 10 and CXCL 11.17 A study by 
Kalliomaki first showed the difference between 
Bifidobacteria and Clostridia in newborns. Diversed 
and balanced gut microbiota are important for 
normal functioning of the immune system.23 Other 
study also showed that in term of gut microbiota 
composition, nutritional intervention might also 
play a role on gut microbiota development and 
showed specific benefit including economic 
effectiveness.24 
 
World.Nutr.Journal | 13  
C-Section delivery is a risk factor for the 
development of allergies and has been linked to 
reduced relative abundance and diversity of 
Bacteroides in first year of life.17,25,26 High 
Bifidobacterium content is considered to lead to 
better immune system development and 
maturation.2 A meta-analysis shows that C-section 
delivery has a lower diversity of gut microbiota 
during the first 3 months of life. At the colonization 
level, Bifidobacterium and Bacteriodes genera in 
vaginally delivered infants seem to be significantly 
more frequent compared to C-section delivered 
infants.8 The presence of Bacteroides was associated 
with high levels of chemokines associated with Th1 
in infancy at 1 month. C-section is associated with 
lower bacterial diversity as described above and 
lower circulating levels of chemokines are 
associated with Th1 in infancy.17 Moreover, Ly et al. 
showed that C-Section delivered infants are 
characterized by increased cytokine IL-13 
production from stimulated cord blood cells.26 This 
suggests higher incidence and severity of asthma 
and atopy caused by gut dysbiosis in these C-section 
infants.  
 
Intervention of gut dysbiosis with synbiotics 
 
The importance of intestinal composition in health, 
especially during early life, suggests that microbial 
interventions may be an effective strategy for 
potential adverse health outcomes. Some possible 
strategies have been employed in the effort to 
achieve a healthy balance of good intestinal 
microbiota such as vaginal seeding, environmental 
exposure, and supplementation.27 The 
supplementation of prebiotics and/or probiotics is 
widely studied. Probiotics are live microorganisms 
that provide hosts with sufficient health benefits 
when administered. The mechanism of these 
probiotics’ positive effects remains unclear. 
Prebiotics is a non-digestible nutritional fiber, which 
has a positive physiological effect for the host by 
selectively stimulating a small number of 
indigenous bacteria to increase their growth or 
activity. Prebiotics is known to boost the growth of 
beneficial bacteria Lactobacillus and Bifidobacteria 
in the upper gastrointestinal tract. Prebiotics produce 
short fatty acids, lactic acids and acetic acids in such 
bacteria, which improve host metabolism, the 
immune system and the gastrointestinal function. 
The immune and metabolic systems combined with 
special prebiotics and probiotics (called synbiotics) 
supplements is thought to have synergistic beneficial 
effects.28  
Breast milk, as the gold standard for infant 
nutrition, not only provides nutrients to the infant 
but is also a source of probiotics (microbiota) and 
prebiotics (HMOs) contributing to the establishment 
of the ideal infant gut microbiota.29 While 
breastfeeding, each milliliter of human milk 
introduces about 103 to 106 bacterial cells into the 
body.30,31 Breast milk microbiota is dominated by 
Staphylococcus, Streptococcus, Propionibacterium 
and Bifidobacterium. The transfer of these 
microorganisms into the neonatal gut is thought to 
protect against infections and contribute to the 
maturation of the immune system.30-32 Human milk 
also contains up to 15 g/L of oligosaccharides, 
whereas only trace amounts are usually found in 
cow’s milk. These human milk oligosaccharides 
(HMO) act as growth substrates for beneficial gut 
microbiota such as Bifidobacteria.33  
Nutritional intervention with pre-, probiotics 
and/or synbiotics may be a cost-effective approach 
to early life dysbiosis and its correlation with 
allergic conditions. Evidence of prebiotic 
supplementation of infant formula with a specific 
mixture of short-chain galacto-oligosaccharides 
(scGOS) and long-chain fructo-oligosaccharides 
(lcFOS) resulting in an intestinal microbiota 
enriched with Bifidobacterium.27 Knol et al34 
research has shown that adding 0.8g/100ml of 
prebiotic scGOS/lcFOS in the infant formula 
enhances the bifidobacterial growth and changes in 
small, breast-fed infant fatty acids, lactate and pH. 
Moreover, a randomized clinical trial demonstrated 
that administration of this specific prebiotic mixture 
early in life continues to be protective against 
eczema development at 6 months and even against 
allergic events up to 5 years, in healthy high-risk 
infants based on family history of allergy.35-37  
Existing publications show that intestinal 
microbiota is typically low in Bifidobacteria and 
Lactobacilla compared to healthy infants in infants 
with allergic conditions.27 Several studies have 
shown conflicting results of the presence of 
Bifidobacteria and their relationship to lower risk 
for developing allergic diseases. Ismail and 
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colleagues assessed the association between various 
species of Bifidobacterium and subsequent eczema 
and atopic sensitization. Bifidobacterium breve at 1 
week and 3 months of age were shown to be 
associated with a lower risk of eczema development 
and sensitization at 12 months of age.38 Probiotics 
supplementation intervention together with 
extensively hydrolyzed casein formula resulted in 
cow's milk protein tolerance that reduced incidence 
of allergic manifestations, including eczema and 
asthma, in children with cow’s milk allergy. In other 
research synbiotics provide supporting evidence in 
reducing the risk of symptoms of asthma and the use 
of asthma medication in children who receive 
synbiotics with extensively hydrolyzed formula 
(eHF). These infants also have higher 
Bifidobacterium and lower Clostridium levels.27 
Research shows the retarded colonization of 
Bifidobacterium spp in infants born through C-
section by modifying gut microbiota with synbiotics 
supplement. Early supplementation with 
scGOS/lcFOS and Bifidobacterium breve (B. breve) 
M-16V (synbiotics) led to immediate 
Bifidobacterium colonization, which suggests that 
the first three months of the life represent an 
opportunity for quick recovery.27 One study showed 
protective effect in dysbiosis of mice with food 
allergy treated with B. breve M16-V.39 A recent 
study has shown that B. breve abundance was 
correlated with protection from development of 
eczema and childhood immune sensitivity.38 Chua et 
al’s25 pioneering evidence has shown that 
supplementation with scGOS/lcFOS and B. breve 
M16-V in C-section-born infants allows rapid 
colonization of bifidobacteria from the first days of 
life and offers promising nutritional intervention in 
dysbiosis. In this study, synbiotic mixture was able 
to re-establish the delayed colonization in elective 
C-section delivered infants from the first days of 
life, and remained significant until 2 months of age. 
Synbiotics created a favorable gut ecosystem milieu 
that contributes in preventing colonization of fast-
growing opportunistic pathogens and potentially 
reduce the development of skin disorders, especially 
eczema in early life in C-section delivered infants. 
World Allergy Organization (WAO) recommends 
using probiotics to children at high risk of 
developing allergy, and also provided conditional 
recommendation for prebiotic supplementation in 
non-exclusively breastfed infants regardless of their 
allergic risk.25,40,41 Although it wasn’t supported 
with a strong certainty of evidence, prebiotic 
supplementation may place a relatively higher value 
on possible prevention of allergies and a relatively 
lower value on additional cost of prebiotic 
supplementation in not exclusively breastfed 
infants.41 The benefits of human milk 
oligosacharides (HMOs) intervention were also 
widely studied and considered safe for infant 
nutrition, including for gut microflora development 
of C-section born babies.42 Thus the use of 
prebiotics on top of probiotics, or in a form of 
synbiotics, in early life may be beneficial to 
compensate for intestinal microbiota disorders, but 
more study is needed on the benefits of patient 
outcomes, particularly in terms of allergic outcomes.  
 
Conclusion 
 
The intestinal microbiota is a very complex entity 
and there are a lot more to learn about the underlying 
processes that shapes microbiota development, 
interactions with the host, and the role of specific 
microbes in health and disease. The first major 
infant exposure that affects gut microbiota is during 
and shortly after birth, especially related to mode of 
delivery and breastfeeding. There is a significant 
difference in the diversity and quantities of gut 
microbiota between infants born through vaginal 
and C-section delivery. Gut microbiota in C-section 
infants is less diversed, and therefore causing 
dysbiosis. Gut microbiota is the main source of 
microbial control by T lymphocytes and gut 
dysbiosis can alter immune developments and 
predispose to some immune disorders later in life 
including allergy, atopy, obesity, diabetes, 
inflammatory bowel diseases and other autoimmune 
diseases. The use of pre- and probiotics, or in the 
form of synbiotics, offers a promising benefit for gut 
dysbiosis especially in C-section born infants as a 
cost-effective strategy to prevent metabolism and 
immune disorders. 
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